A business in context

PBSV research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-14 · 0001654954-26-008347 · Items 2.02,9.01

  2. 10-Q · Quarterly report

    Report date 2026-07-31 · 0001654954-26-008346

  3. 4 · Ownership change

    Report date 2026-06-09 · 0001654954-26-006801

  4. 8-K · Current report

    Report date 2026-06-15 · 0001654954-26-005989 · Items 2.02,9.01

  5. 10-Q · Quarterly report

    Report date 2026-04-30 · 0001654954-26-005986

  6. 8-K · Current report

    Report date 2026-05-15 · 0001654954-26-005006 · Items 5.07,9.01

  7. DEF 14A · Proxy statement

    Report date 2026-04-15 · 0001654954-26-003617

  8. 8-K · Current report

    Report date 2026-03-17 · 0001654954-26-002338 · Items 2.02,9.01

  9. 10-Q · Quarterly report

    Report date 2026-01-31 · 0001654954-26-002336

  10. 10-K/A · Annual report

    Report date 2025-10-31 · 0001654954-26-001674

  11. 8-K · Current report

    Report date 2026-01-29 · 0001654954-26-000712 · Items 2.02,9.01

  12. 10-K · Annual report

    Report date 2025-10-31 · 0001654954-26-000710

  13. 4 · Ownership change

    Report date 2026-01-10 · 0001654954-26-000353

  14. 4 · Ownership change

    Report date 2026-01-10 · 0001654954-26-000352

  15. 4 · Ownership change

    Report date 2026-01-10 · 0001654954-26-000349

  16. 4 · Ownership change

    Report date 2026-01-10 · 0001654954-26-000347

  17. 8-K · Current report

    Report date 2025-09-15 · 0001654954-25-010776 · Items 2.02,9.01

  18. 10-Q · Quarterly report

    Report date 2025-07-31 · 0001654954-25-010775

  19. 8-K · Current report

    Report date 2025-06-16 · 0001654954-25-007011 · Items 2.02,9.01

  20. 10-Q · Quarterly report

    Report date 2025-04-30 · 0001654954-25-007009

  21. 8-K · Current report

    Report date 2025-05-15 · 0001654954-25-005812 · Items 5.07,9.01

  22. DEF 14A · Proxy statement

    Report date 2025-04-12 · 0001654954-25-004485

  23. 8-K · Current report

    Report date 2025-03-17 · 0001654954-25-002892 · Items 2.02,9.01

  24. 10-Q · Quarterly report

    Report date 2025-01-31 · 0001654954-25-002888

  25. 10-K/A · Annual report

    Report date 2024-10-31 · 0001654954-25-002155

  26. 8-K · Current report

    Report date 2025-01-29 · 0001654954-25-000919 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-01-29 · 0001654954-25-000918 · Items 8.01,9.01

  28. 10-K · Annual report

    Report date 2024-10-31 · 0001654954-25-000915

  29. 4 · Ownership change

    Report date 2025-01-10 · 0001654954-25-000425

  30. 4 · Ownership change

    Report date 2025-01-10 · 0001654954-25-000424

  31. 4 · Ownership change

    Report date 2025-01-10 · 0001654954-25-000423

  32. 8-K · Current report

    Report date 2024-09-16 · 0001654954-24-011974 · Items 2.02,9.01

  33. 10-Q · Quarterly report

    Report date 2024-07-31 · 0001654954-24-011967

  34. 8-K · Current report

    Report date 2024-06-14 · 0001654954-24-007798 · Items 2.02,9.01

  35. 10-Q · Quarterly report

    Report date 2024-04-30 · 0001654954-24-007794

  36. 8-K · Current report

    Report date 2024-05-02 · 0001654954-24-005476 · Items 5.02,5.07,9.01

  37. DEF 14A · Proxy statement

    Report date 2024-04-04 · 0001654954-24-004363

  38. 8-K · Current report

    Report date 2024-03-18 · 0001654954-24-003318 · Items 2.02,9.01

  39. 10-Q · Quarterly report

    Report date 2024-01-31 · 0001654954-24-003314

  40. 10-K/A · Annual report

    Report date 2023-10-31 · 0001654954-24-002305

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

1 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-09
2026-07-22
SPINDEL HOWARDJ · Other (see filing)
Disposed
Common Stock42504.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001304161Pharma-Bio Serv, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • LAWRENCE CONSULTING GROUP INC · former SEC name · 2004-09-24 to 2006-02-28

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-10-31$9.51M$10.26M
2023-10-31$16.98M$18.87M
2022-10-31$19.40M$22.57M
2021-10-31$20.12M$25.29M
2020-10-31$21.56M$28.13M
2019-10-31$19.51M$25.80M
2018-10-31$17.80M$23.96M

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗